Relevium Technologies Inc
Relevium Technologies Inc. engages in the identification, evaluation, acquisition, and operation of brands and businesses in the health and wellness markets with a focus on e-commerce. The company markets dietary supplements, nutraceuticals, sports nutrition products, and cosmeceuticals primarily through its Bioganix brand portfolio online; dietary supplements under the LeefyLyfe brand; and skin … Read more
Relevium Technologies Inc (RLLVF) - Net Assets
Latest net assets as of March 2022: $-1.14 Million USD
Based on the latest financial reports, Relevium Technologies Inc (RLLVF) has net assets worth $-1.14 Million USD as of March 2022.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($3.02 Million) and total liabilities ($4.16 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-1.14 Million |
| % of Total Assets | -37.63% |
| Annual Growth Rate | N/A |
| 5-Year Change | -476.09% |
| 10-Year Change | N/A |
| Growth Volatility | 2976.6 |
Relevium Technologies Inc - Net Assets Trend (2013–2021)
This chart illustrates how Relevium Technologies Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Relevium Technologies Inc (2013–2021)
The table below shows the annual net assets of Relevium Technologies Inc from 2013 to 2021.
| Year | Net Assets | Change |
|---|---|---|
| 2021-06-30 | $-4.90 Million | -8932.47% |
| 2020-06-30 | $55.52K | -98.90% |
| 2019-06-30 | $5.05 Million | +30.04% |
| 2018-06-30 | $3.88 Million | +197.73% |
| 2017-06-30 | $1.30 Million | +204.22% |
| 2016-06-30 | $428.62K | +190.90% |
| 2015-06-30 | $147.34K | -56.76% |
| 2014-06-30 | $340.79K | -39.12% |
| 2013-06-30 | $559.75K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Relevium Technologies Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 2358198700.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (June 2021)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $14.18 Million | % |
| Other Comprehensive Income | $15.39K | % |
| Other Components | $4.72 Million | % |
| Total Equity | $-4.90 Million | 100.00% |
Relevium Technologies Inc Competitors by Market Cap
The table below lists competitors of Relevium Technologies Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Minnova Corp
PINK:AGRDF
|
$1.91 Million |
|
Gusbourne PLC
PINK:SLLFF
|
$1.91 Million |
|
Ovanti Ltd
AU:OVT
|
$1.92 Million |
|
1844 Resources Inc
V:EFF
|
$1.92 Million |
|
Tectonic Metals Inc
OTCQB:TETOF
|
$1.91 Million |
|
Stern Groep N.V.
AS:PBH
|
$1.91 Million |
|
Drago entertainment S.A.
WAR:DGE
|
$1.91 Million |
|
Wawel S.A.
F:0K6
|
$1.91 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Relevium Technologies Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2020 to 2021, total equity changed from 55,522 to -4,903,962, a change of -4,959,484 (-8932.5%).
- Net loss of 5,368,336 reduced equity.
- New share issuances of 92,747 increased equity.
- Other comprehensive income increased equity by 57,784.
- Other factors increased equity by 258,321.
Equity Change Factors (2020 to 2021)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-5.37 Million | -109.47% |
| Share Issuances | $92.75K | +1.89% |
| Other Comprehensive Income | $57.78K | +1.18% |
| Other Changes | $258.32K | +5.27% |
| Total Change | $- | -8932.47% |
Book Value vs Market Value Analysis
This analysis compares Relevium Technologies Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2013-06-30 | $0.07 | $0.01 | x |
| 2014-06-30 | $0.06 | $0.01 | x |
| 2015-06-30 | $0.02 | $0.01 | x |
| 2016-06-30 | $0.02 | $0.01 | x |
| 2017-06-30 | $0.04 | $0.01 | x |
| 2018-06-30 | $0.05 | $0.01 | x |
| 2019-06-30 | $0.04 | $0.01 | x |
| 2020-06-30 | $0.00 | $0.01 | x |
| 2021-06-30 | $-0.02 | $0.01 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Relevium Technologies Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -587.57%
- • Asset Turnover: 1.20x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-1478.14%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | -42.46% | 0.00% | 0.00x | 1.12x | $-293.66K |
| 2014 | -64.25% | -392.66% | 0.12x | 1.33x | $-253.04K |
| 2015 | -131.29% | 0.00% | 0.00x | 2.61x | $-208.18K |
| 2016 | -279.84% | 0.00% | 0.00x | 1.80x | $-1.24 Million |
| 2017 | -152.63% | 0.00% | 0.00x | 4.20x | $-2.12 Million |
| 2018 | -74.51% | -69.66% | 0.64x | 1.68x | $-3.28 Million |
| 2019 | -73.83% | -102.71% | 0.42x | 1.70x | $-4.23 Million |
| 2020 | -12484.47% | -233.06% | 0.69x | 78.07x | $-6.94 Million |
| 2021 | 0.00% | -587.57% | 1.20x | 0.00x | $-4.88 Million |
Industry Comparison
This section compares Relevium Technologies Inc's net assets metrics with peer companies in the Pharmaceutical Retailers industry.
Industry Context
- Industry: Pharmaceutical Retailers
- Average net assets among peers: $239,198,060
- Average return on equity (ROE) among peers: -6.39%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Relevium Technologies Inc (RLLVF) | $-1.14 Million | -42.46% | N/A | $1.91 Million |
| Alibaba Health Information Technology Limited (ALBBY) | $1.12 Billion | -18.54% | 0.50x | $12.50 Billion |
| Allstar Health Brands Inc (ALST) | $-9.92 Million | 0.00% | 0.00x | $3.83 |
| Bimi International Medical Inc (BIMI) | $-409.66K | 0.00% | 0.00x | $296.83 |
| Blum Holdings Inc (BLMH) | $-4.74 Million | 0.00% | 0.00x | $8.97 Million |
| China Jo-Jo Drugstores Inc (CJJD) | $26.66 Million | -21.17% | 1.52x | $5.94 Million |
| Clicks Group Ltd (CLCGY) | $1.13 Billion | 41.98% | 2.72x | $4.80 Billion |
| China BCT Pharmacy Group Inc (CNBI) | $134.27 Million | 15.68% | 0.82x | $0.96 |
| Dalrada Financial Corp (DFCO) | $4.40 Million | -81.82% | 0.55x | $1.57 Million |
| Health Advance Inc (HADV) | $-105.34K | 0.00% | 0.00x | $25.40K |
| Healthwarehouse.Com (HEWA) | $-3.10 Million | 0.00% | 0.00x | $720.96 |